BROWSE·page 41 of 603

Browse EX-10 agreements

7,230 matching material contract exhibits.


EX-10.2

VISTA CREDIT STRATEGIC LENDING CORP.

Execution Version

AMENDMENT NO. 2 TO
SENIOR SECURED REVOLVING CREDIT AGREEMENT

This AMENDMENT NO. 2 (this “Amendment”), dated as of September 29, 2026, and effective as of Amendment No. 2 Effective Date (as defined below), by and among VISTA CREDIT STRATEGIC LENDING CORP., a Maryland corporation (the “Borrower”), ING CAPITAL LLC, as administrative agent for the Lenders (as defined below) under the Credit Agreement (as defined below) (in such capacity, together with its successors in such capacity, the “Administrative Agent”), the Consenting Lenders (as defined below), and, solely for purposes of Section 2.9, the entities identified as Subsidiary Guarantors on the signature pages hereto (the “Subsidiary Guarantors” and, together with the Borrower, the “Obligors”), is made with respect to the Senior Secured Revolving Credit Agreement, dated as of September 5, 2025 (as amended by that certain Amendment No. 1 to Senior Secured Revolving Credit Agreement, dated as of January 30, 2026, and as further amended, restated, amended and restated, supplemented or otherwise modified from time t

…

EX-10.2·8-K·CIK 1919369·ACC 0001193125-26-414004·Filed Oct 05, 2026, 15:07 ET

EX-10.1

VISTA CREDIT STRATEGIC LENDING CORP.

Execution Version

VISTA CREDIT STRATEGIC LENDING CORP.

SUPPLEMENT NO.1TO MASTER NOTE PURCHASE AGREEMENT

Dated as of September 29, 2026

$150,000,000 7.75% Series 2026A Senior Notes, due October 2, 2028


VISTA CREDIT STRATEGIC LENDING CORP.

Dated as of

September 29, 2026

To the Additional Purchaser(s) named in

Schedule A hereto

Ladies and Gentlemen:

This Supplement No. 1 to Master Note Purchase Agreement (this “Supplement”) is between Vista Credit Strategic Lending Corp., a Maryland corporation (the “Company”), and the institutional investors named on Schedule A attached hereto (the “Additional Purchasers”).

…

EX-10.1·8-K·CIK 1919369·ACC 0001193125-26-414004·Filed Oct 05, 2026, 15:07 ET

EXCHANGE AGREEMENT

Omnitek Engineering Corp

EX-10.1·8-K·CIK 1404804·ACC 0001096906-26-001505·Filed Oct 05, 2026, 14:25 ET

EX-10.1

Jaguar Health, Inc.

**CONSENT AND WAIVER **

This Consent and Waiver (this “Consent and Waiver”) is entered into effective as of October 2, 2026, by and between Jaguar Health, Inc., a Delaware corporation (the “Company”), and each buyer identified on the signature pages hereto (each, including its successors and assigns, a “Buyer” and collectively, the “Buyers”), pursuant to those certain preferred stock purchase agreements, dated as of June 9, 2026, each by and between the Company and the Buyer named therein (collectively the “Purchase Agreements”). Capitalized terms used herein but not otherwise defined herein shall have the meaning set forth in the Purchase Agreements.

**RECITALS **

…

EX-10.1·8-K·CIK 1585608·ACC 0001193125-26-413233·Filed Oct 05, 2026, 08:45 ET

Execution Version

LETTER OF INTENT

** **

October 2, 2026

SIM Acquisition Corp. I

Attn: Board of Directors

Re: Proposed Business Combination with American Industrial Technologies, Inc.

*** ***

Ladies and Gentlemen:

This Letter of Intent (this “Letter”) sets forth the principal terms pursuant to which American Industrial Technologies, Inc., a Nevada corporation formerly known as Q1 Holdings, Inc. (together with its subsidiaries to the extent reasonably applicable, the “Company”), proposes to consummate a business combination with SIM Acquisition Corp. I, a Cayman Islands exempted company (“SPAC”) (the “Proposed Transaction”). SPAC and the Company are sometimes referred to herein individually as a **“Party” **and collectively as the “Parties.”

** **

This Letter replaces and supersedes in its entirety that certain non-binding Letter of Intent, dated April 26, 2026, between SPAC and the Company (the “Original Letter Agreement”).

** **

1. Transaction Overview.

…

EX-10.1·8-K·CIK 2014982·ACC 0001213900-26-106662·Filed Oct 05, 2026, 08:32 ET

EX-10.1

Immunome Inc.

CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THAT IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

**AMENDMENT NO. 4 TO LICENSE AGREEMENT **

This AMENDMENT NO. 4 TO LICENSE AGREEMENT (“Amendment No.********* 4***”) made and effective as of October 2, 2026 (the “Amendment No.********* 4 Effective Date***”), is by and between Immunome, Inc., a Delaware corporation with offices at 18702 N Creek Parkway South, Suite #100, Bothell, WA 98011 (“Immunome”) and Bristol-Myers Squibb Company, a Delaware corporation with offices at Route 206 and Province Line Road, Princeton, New Jersey 08543 (“BMS”). Immunome and BMS are together referred to in this Amendment No. 4 as the “Parties” and individually as a “Party.”

**Background: **

…

EX-10.1·8-K·CIK 1472012·ACC 0001193125-26-413217·Filed Oct 05, 2026, 08:30 ET

EX-10.1

Leidos Holdings, Inc.

**CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. **

Schedules 1.1, 1.2, 1.3, 6.03(a)(xiii), 13.02(a) and I, and Exhibit B, have each been omitted pursuant to Item 601(a)(5) of Regulation S-K. Schedule 1.1 lists the Approved Banks, Schedule 1.2 lists the Ministerial Matters, Schedule 1.3 lists the Additional Grandfathered Territories, Schedule 6.03(a)(xiii) sets out a threshold relating to a special approval right in respect of Management Incentive Plans, Schedule 13.02(a) sets out financial reporting requirements, Schedule I lists the initial Officers and Exhibit B is the form of Registration Rights Agreement. The registrant will furnish a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.

AMENDED AND RESTATED

LIMITED LIABILITY COMPANY AGREEMENT

of

NICKEL JV ULTIMATE PARENT, LLC

Dated as of October 5, 2026

…

EX-10.1·8-K·CIK 1336920·ACC 0001193125-26-413208·Filed Oct 05, 2026, 08:21 ET

EX-10.1

C. H. ROBINSON WORLDWIDE, INC.

**VOTING AND SUPPORT AGREEMENT **

This VOTING AND SUPPORT AGREEMENT, dated as of October 4, 2026 (this “Agreement”), is entered into by and between C.H. Robinson Worldwide, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder of the Company (as defined below) (the “Stockholder”). Capitalized terms used but not defined herein shall have the respective meanings set forth in the Merger Agreement (as defined below).

…

EX-10.1·8-K·CIK 1043277·ACC 0001193125-26-413203·Filed Oct 05, 2026, 08:20 ET

EXHIBIT 10.1

RED ROBIN GOURMET BURGERS INC

EXECUTION VERSION

CREDIT AGREEMENT

dated as of October 2, 2026, among

RED ROBIN INTERNATIONAL, INC.,

as Borrower,

RED ROBIN GOURMET BURGERS, INC.,

as Holdings,

THE LENDERS AND ISSUING BANKS PARTY HERETO

TEXAS CAPITAL BANK,

as Documentation Agent,

JPMORGAN CHASE BANK, N.A.,

as Administrative Agent and Collateral Agent and

JPMORGAN CHASE BANK, N.A.,
and U.S. BANK NATIONAL ASSOCIATION,

as Joint Lead Arrangers and Joint Bookrunners

TABLE OF CONTENTS

Page

…

EX-10.1·8-K·CIK 1171759·ACC 0001104659-26-113514·Filed Oct 05, 2026, 08:20 ET

EXHIBIT 10.2

RED ROBIN GOURMET BURGERS INC

EXECUTION VERSION

PLEDGE AND SECURITY AGREEMENT

dated and effective as of

October 2, 2026

among

RED ROBIN GOURMET BURGERS, INC.,

as Holdings,

RED ROBIN INTERNATIONAL, INC.,

as the Borrower,

each Subsidiary Loan Party

party hereto

and

JPMORGAN CHASE BANK, N.A.,

as Collateral Agent

TABLE OF CONTENTS

…

EX-10.2·8-K·CIK 1171759·ACC 0001104659-26-113514·Filed Oct 05, 2026, 08:20 ET

EXHIBIT 10.1

RXO, Inc.


Exhibit 10.1

Execution Version

VOTING AND SUPPORT AGREEMENT

This VOTING AND SUPPORT AGREEMENT, dated as of October 4, 2026 (this “Agreement”), is entered into by and between C.H. Robinson Worldwide, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder of the Company (as defined below) (the “Stockholder”). Capitalized terms used but not defined herein shall have the respective meanings set forth in the Merger Agreement (as defined below).

…

EX-10.1·8-K·CIK 1929561·ACC 0001140361-26-038548·Filed Oct 05, 2026, 08:17 ET

EX-10.1

FLEX LTD.

**Certain confidential information contained in this document, marked by [****], has been omitted because it is both (i) not material and (ii) the type that the Company treats as private or confidential. **

**EXECUTION VERSION **

**Axiom Solutions International, Inc. **

**Series A Convertible Preferred Stock Investment Agreement **

Dated as of October 2, 2026


**TABLE OF CONTENTS **

Page

…

EX-10.1·8-K·CIK 866374·ACC 0001193125-26-413173·Filed Oct 05, 2026, 08:07 ET